CorMedix (CRMD) announces it has engaged with WSI PBG, a subsidiary of Golden State Medical Supply, to promote DefenCath to healthcare providers in facilities operated by the Department of Veterans Affairs and other federal facilities. This collaboration aims to enhance access to critical therapies for the estimated 40,000 veterans living with end-stage renal disease and other beneficiaries of federal programs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRMD:
- CorMedix initiated with a Buy at D. Boral Capital
- Biotech Alert: Searches spiking for these stocks today
- Paychex to acquire Paycor HCM, Getty and Shutterstock to merge: Morning Buzz
- CorMedix up 22% at $9.66 in pre-market after Q4 revenue pre-announcement
- CorMedix reports preliminary Q4 net revenue $31M